Osteoclast Activity and Subtypes as a Function of Physiology and Pathology-Implications for Future Treatments of Osteoporosis

被引:185
作者
Henriksen, K. [1 ]
Bollerslev, J. [2 ,3 ]
Everts, V. [4 ,5 ]
Karsdal, M. A. [1 ]
机构
[1] Nord Biosci AS, Hovedgade 207, DK-2730 Herlev, Denmark
[2] Natl Hosp Norway, Oslo Univ Hosp, Dept Med, Sect Endocrinol, N-0450 Oslo, Norway
[3] Univ Oslo, N-0450 Oslo, Norway
[4] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Oral Cell Biol, NL-1066 EA Amsterdam, Netherlands
[5] Vrije Univ Amsterdam, Res Inst Move, NL-1066 EA Amsterdam, Netherlands
关键词
RESISTANT ACID-PHOSPHATASE; AUTOSOMAL-DOMINANT OSTEOPETROSIS; BONE-MINERAL DENSITY; TUMOR-NECROSIS-FACTOR; MATRIX-METALLOPROTEINASE INHIBITORS; ESTROGEN-RECEPTOR-ALPHA; CATHEPSIN-K INHIBITOR; GLUCOCORTICOID-INDUCED OSTEOPOROSIS; HORMONE REPLACEMENT THERAPY; CARTILAGE TURNOVER MARKERS;
D O I
10.1210/er.2010-0006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteoclasts have traditionally been associated exclusively with catabolic functions that are a prerequisite for bone resorption. However, emerging data suggest that osteoclasts also carry out functions that are important for optimal bone formation and bone quality. Moreover, recent findings indicate that osteoclasts have different subtypes depending on their location, genotype, and possibly in response to drug intervention. The aim of the current review is to describe the subtypes of osteoclasts in four different settings: 1) physiological, in relation to turnover of different bone types; 2) pathological, as exemplified by monogenomic disorders; 3) pathological, as identified by different disorders; and 4) in drug-induced situations. The profiles of these subtypes strongly suggest that these osteoclasts belong to a heterogeneous cell population, namely, a diverse macrophage-associated cell type with bone catabolic and anabolic functions that are dependent on both local and systemic parameters. Further insight into these osteoclast subtypes may be important for understanding cell-cell communication in the bone microenvironment, treatment effects, and ultimately bone quality. (Endocrine Reviews 32: 31-63, 2011)
引用
收藏
页码:31 / 63
页数:33
相关论文
共 381 条
  • [1] Mechanisms by which extracellular matrix components induce osteoblast apoptosis
    Adams, CS
    Shapiro, IM
    [J]. CONNECTIVE TISSUE RESEARCH, 2003, 44 : 230 - 239
  • [2] Erosive Arthritis in a Patient With Pycnodysostosis An Experiment of Nature
    Ainola, Mari
    Valleala, Heikki
    Nykanen, Pekka
    Risteli, Juha
    Hanemaaijer, Roeland
    Konttinen, Yrjo T.
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (11): : 3394 - 3401
  • [3] Biology of breast cancer bone metastasis
    Akhtari, Mojtaba
    Mansuri, Junaid
    Newman, Kam A.
    Guise, Theresa M.
    Seth, Prem
    [J]. CANCER BIOLOGY & THERAPY, 2008, 7 (01) : 3 - 9
  • [4] Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (Type II autosomal dominant osteopetrosis)
    Alatalo, SL
    Ivaska, KK
    Waguespack, SG
    Econs, MJ
    Väänänen, HK
    Halleen, JM
    [J]. CLINICAL CHEMISTRY, 2004, 50 (05) : 883 - 890
  • [5] ALBERSSCHONBERG HE, 2004, RONTGENBILDER SELTEN, P365
  • [6] Risedronate reduces osteoclast precursors and cytokine production in postmenopausal osteoporotic women
    Amelio, Patrizia D.
    Grimaldi, Anastasia
    Di Bella, Stefania
    Tamone, Cristina
    Brianza, Stefano Z. M.
    Ravazzoli, Marco G. A.
    Bernabei, Paola
    Cristofaro, Maria Angela
    Pescarmona, Gian Piero
    Isaia, Giancarlo
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 (03) : 373 - 379
  • [7] Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters
    Arlot, M
    Meunier, PJ
    Boivin, G
    Haddock, L
    Tamayo, J
    Correa-Rotter, R
    Jasqui, S
    Donley, DW
    Dalsky, GP
    San Martin, J
    Eriksen, EF
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (07) : 1244 - 1253
  • [8] Arlot M E, 1990, Osteoporos Int, V1, P41, DOI 10.1007/BF01880415
  • [9] Histomorphometric and μCT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate
    Arlot, Monique E.
    Jiang, Yebin
    Genant, Harry K.
    Zhao, Jenny
    Burt-Pichat, Brigitte
    Roux, Jean-Paul
    Delmas, Pierre D.
    Meunier, Pierre J.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 (02) : 215 - 222
  • [10] Inhibition of Interleukin-6 Receptor Directly Blocks Osteoclast Formation In Vitro and In Vivo
    Axmann, Roland
    Boehm, Christina
    Kroenke, Gerhard
    Zwerina, Jochen
    Smolen, Josef
    Schett, Georg
    [J]. ARTHRITIS AND RHEUMATISM, 2009, 60 (09): : 2747 - 2756